R1 RCM Inc. is an American revenue cycle management company servicing hospitals, health systems and physician groups across the United States.
Company profile
Ticker
RCM
Exchange
Website
CEO
Joseph Gerard Flanagan
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
PROJECT ROADRUNNER PARENT INC.
SEC CIK
Corporate docs
Subsidiaries
Accretive Health Mauritius, Inc. • Acclara, LLC • Acclara Holdings Group, Inc. • Acclara Solutions, LLC • Acclara Solutions Group, LLC • Acclara Solutions Intermediate, LLC • Acustream, LLC • Advata Inc. • Alphalytics LLC • AS Buyer, Inc. ...
IRS number
20698101
RCM stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
12 Apr 24
DEFA14A
Additional proxy soliciting materials
12 Apr 24
DEF 14A
Definitive proxy
12 Apr 24
8-K
Other Events
19 Mar 24
10-K
2023 FY
Annual report
27 Feb 24
8-K
R1 RCM Reports Fourth Quarter and Full Year 2023 Results
27 Feb 24
8-K
Departure of Directors or Certain Officers
15 Feb 24
8-K
Entry into a Material Definitive Agreement
6 Feb 24
8-K
R1 RCM Completes Acquisition of Acclara, Providence’s Modular Services Business
17 Jan 24
8-K
R1 RCM Announces Preliminary Fourth Quarter Results
8 Jan 24
Transcripts
RCM
Earnings call transcript
2023 Q4
27 Feb 24
RCM
Earnings call transcript
2023 Q3
2 Nov 23
RCM
Earnings call transcript
2023 Q2
2 Aug 23
RCM
Earnings call transcript
2023 Q1
4 May 23
RCM
Earnings call transcript
2022 Q4
16 Feb 23
RCM
Earnings call transcript
2022 Q3
8 Nov 22
RCM
Earnings call transcript
2022 Q2
3 Aug 22
RCM
Earnings call transcript
2021 Q1
4 May 21
Latest ownership filings
4
JOSEPH GERARD FLANAGAN
28 Mar 24
4
JOHN M. SPARBY
12 Mar 24
SC 13D/A
TCP-ASC ACHI Series LLLP
11 Mar 24
4
JOHN M. SPARBY
8 Mar 24
144
Notice of proposed sale of securities
7 Mar 24
4
Pamela L. Spikner
28 Feb 24
4
JOHN M. SPARBY
28 Feb 24
SC 13D/A
New Mountain Investments V, L.L.C.
26 Feb 24
3
Pamela L. Spikner
22 Feb 24
SC 13D/A
New Mountain Investments V, L.L.C.
7 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 227 |
Opened positions | 31 |
Closed positions | 32 |
Increased positions | 95 |
Reduced positions | 58 |
13F shares | Current |
---|---|
Total value | 3.79 tn |
Total shares | 552.40 mm |
Total puts | 5.09 mm |
Total calls | 3.05 mm |
Total put/call ratio | 1.7 |
Largest owners | Shares | Value |
---|---|---|
TCP-ASC ACHI Series LLLP | 164.75 mm | $2.48 bn |
Mountain Investments V, L.L.C. New | 135.99 mm | $2.05 bn |
New Mountain Capital, L.L.C. | 94.41 mm | $1.42 tn |
Vanguard | 17.94 mm | $270.37 bn |
BLK Blackrock | 17.17 mm | $258.74 bn |
Citadel Advisors | 10.27 mm | $154.72 bn |
Capital International Investors | 8.28 mm | $124.72 bn |
BK Bank Of New York Mellon | 7.02 mm | $105.76 bn |
MS Morgan Stanley | 6.80 mm | $102.43 bn |
IVZ Invesco | 5.12 mm | $77.17 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Mar 24 | John M. Sparby | Common Stock | Other | Dispose J | No | No | 0 | 3,101 | 0.00 | 262,885 |
7 Mar 24 | John M. Sparby | Common Stock | Sell | Dispose S | Yes | No | 14.33 | 10,046 | 143.96 k | 0 |
6 Mar 24 | John M. Sparby | Common Stock | Other | Dispose J | No | No | 0 | 3,750 | 0.00 | 265,986 |
27 Feb 24 | Pamela L. Spikner | Common Stock | Grant | Acquire A | No | No | 0 | 8,953 | 0.00 | 25,753 |
27 Feb 24 | John M. Sparby | Common Stock | Payment of exercise | Dispose F | No | No | 14.58 | 10,748 | 156.71 k | 269,736 |
27 Feb 24 | John M. Sparby | Common Stock | Grant | Acquire A | No | No | 0 | 36,657 | 0.00 | 280,484 |
27 Feb 24 | Flanagan Joseph Gerard | Common Stock | Payment of exercise | Dispose F | No | No | 14.58 | 55,825 | 813.93 k | 3,371,490 |
27 Feb 24 | Flanagan Joseph Gerard | Common Stock | Grant | Acquire A | No | No | 0 | 148,849 | 0.00 | 3,427,315 |
News
Cantor Fitzgerald Reiterates Overweight on R1 RCM, Maintains $20 Price Target
10 Apr 24
Keybanc Downgrades R1 RCM to Sector Weight
10 Apr 24
The Latest Analyst Ratings For R1 RCM
5 Apr 24
Guggenheim Maintains Buy on R1 RCM, Lowers Price Target to $15
5 Apr 24
Truist Securities Maintains Hold on R1 RCM, Maintains $16 Price Target
1 Apr 24
Press releases
R1 RCM to Release First Quarter 2024 Results on May 8, 2024
1 Apr 24
R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report
27 Mar 24
R1 RCM Inc. (RCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
1 Mar 24
R1 RCM Inc. (RCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
28 Feb 24
Coliseum Capital Issues Open Letter to Board of R1 RCM on Offer by New Mountain to Acquire the Company for $13.75 Per Share
26 Feb 24